JP2015521630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521630A5 JP2015521630A5 JP2015518721A JP2015518721A JP2015521630A5 JP 2015521630 A5 JP2015521630 A5 JP 2015521630A5 JP 2015518721 A JP2015518721 A JP 2015518721A JP 2015518721 A JP2015518721 A JP 2015518721A JP 2015521630 A5 JP2015521630 A5 JP 2015521630A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- adipose tissue
- stem cells
- stromal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000577 adipose tissue Anatomy 0.000 claims description 28
- 210000004504 adult stem cell Anatomy 0.000 claims description 19
- 210000001185 bone marrow Anatomy 0.000 claims description 15
- 206010019233 Headaches Diseases 0.000 claims description 13
- 231100000869 headache Toxicity 0.000 claims description 13
- 210000000130 stem cell Anatomy 0.000 claims description 13
- 210000002536 stromal cell Anatomy 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 230000002792 vascular Effects 0.000 claims description 9
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 230000000735 allogeneic effect Effects 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 210000004623 platelet-rich plasma Anatomy 0.000 claims description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 3
- 210000002744 extracellular matrix Anatomy 0.000 claims description 3
- 210000004700 fetal blood Anatomy 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 210000002826 placenta Anatomy 0.000 claims description 3
- 210000003954 umbilical cord Anatomy 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 208000006561 Cluster Headache Diseases 0.000 claims description 2
- 102000029816 Collagenase Human genes 0.000 claims description 2
- 108060005980 Collagenase Proteins 0.000 claims description 2
- 208000019695 Migraine disease Diseases 0.000 claims description 2
- 206010043269 Tension headache Diseases 0.000 claims description 2
- 208000008548 Tension-Type Headache Diseases 0.000 claims description 2
- 210000001789 adipocyte Anatomy 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 208000018912 cluster headache syndrome Diseases 0.000 claims description 2
- 229960002424 collagenase Drugs 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 206010027599 migraine Diseases 0.000 claims description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000010907 mechanical stirring Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 23
- 239000000203 mixture Substances 0.000 description 4
- 238000013019 agitation Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012902720A AU2012902720A0 (en) | 2012-06-26 | Compositions and methods for reducing frequency and/or severity of headache | |
| AU2012902720 | 2012-06-26 | ||
| PCT/AU2013/000684 WO2014000029A1 (en) | 2012-06-26 | 2013-06-26 | Compositions and methods for reducing frequency and/or severity of headache |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015521630A JP2015521630A (ja) | 2015-07-30 |
| JP2015521630A5 true JP2015521630A5 (enExample) | 2016-08-04 |
Family
ID=49781943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015518721A Pending JP2015521630A (ja) | 2012-06-26 | 2013-06-26 | 頭痛の頻度および／または重症度を下げるための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10206956B2 (enExample) |
| EP (1) | EP2863927A4 (enExample) |
| JP (1) | JP2015521630A (enExample) |
| KR (1) | KR20150091037A (enExample) |
| CN (1) | CN104902909A (enExample) |
| AU (1) | AU2013284338B2 (enExample) |
| CA (1) | CA2877022A1 (enExample) |
| NZ (1) | NZ703345A (enExample) |
| WO (1) | WO2014000029A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2994147A4 (en) * | 2013-05-10 | 2017-03-08 | Cell-Innovations IP Pty Ltd | Compositions and methods for the treatment of tinnitus |
| KR20160027127A (ko) * | 2013-07-01 | 2016-03-09 | 아미트 프라카시 고빌 | 연조직 임플란트 |
| US10456419B2 (en) | 2017-02-27 | 2019-10-29 | Payman Sadeghi | Method for treating migraine headaches |
| US10932711B2 (en) | 2017-02-27 | 2021-03-02 | Payman Sadeghi | Method and system for neurohydrodissection |
| JP6829225B2 (ja) * | 2018-06-13 | 2021-02-10 | 株式会社 バイオミメティクスシンパシーズ | モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物 |
| CN110772535A (zh) * | 2018-07-12 | 2020-02-11 | 南通大学 | 多系分化持续应激细胞在制备镇痛药物中的应用 |
| JP6497827B1 (ja) * | 2018-07-17 | 2019-04-10 | 株式会社 バイオミメティクスシンパシーズ | エイコサノイド産生促進剤 |
| WO2020084135A1 (en) | 2018-10-26 | 2020-04-30 | Stemselect | Method and apparatus for mesenchymal stem cells isolation and purification |
| WO2022104069A1 (en) * | 2020-11-13 | 2022-05-19 | Advanced Therapeutic Lab, Inc. | Therapeutic methods and compositions utilizing stromal vascular fraction derived from adipose tissue |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2306335C2 (ru) * | 1999-03-10 | 2007-09-20 | Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Стволовые клетки и решетки, полученные из жировой ткани |
| JP2005533480A (ja) * | 2001-11-09 | 2005-11-10 | アーテセル・サイエンシズ・インコーポレーテツド | 脂肪組織由来間質細胞の膵内分泌分化およびその使用 |
| ES2375565T3 (es) * | 2003-08-07 | 2012-03-02 | Healor Ltd. | Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas. |
| AU2004280616A1 (en) | 2003-10-08 | 2005-04-21 | Vet-Stem Inc. | Methods of preparing and using stem cell compositions and kits comprising the same |
| FR2901136B1 (fr) * | 2006-05-18 | 2010-10-01 | Centre Nat Rech Scient | Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral |
| JP2010037292A (ja) | 2008-08-06 | 2010-02-18 | Univ Of Tokyo | 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法 |
| NZ591292A (en) * | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
| CA2734237C (en) * | 2008-08-20 | 2019-07-02 | Anthrogenesis Corporation | Treatment of stroke using isolated placental cells |
| WO2010071862A1 (en) * | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
| AU2009100401A4 (en) * | 2009-04-30 | 2009-06-04 | Gl Holdings Inc Bv | Method of extracting and activating adipose-derived stem cells |
| EP2424463B1 (en) * | 2009-05-01 | 2016-12-28 | Bimini Technologies LLC | Systems, methods and compositions for optimizing tissue and cell enriched grafts |
| JP2011010581A (ja) | 2009-06-30 | 2011-01-20 | Kaneka Corp | 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法 |
| JP5905446B2 (ja) | 2010-03-24 | 2016-04-20 | ライフネット ヘルス | Ｂｍｐ−４ペプチドおよび使用方法 |
| WO2011138786A2 (en) * | 2010-05-06 | 2011-11-10 | Stem Cell Medicine Ltd. | Stem cell bank for personalized medicine |
| KR20200116546A (ko) * | 2010-12-17 | 2020-10-12 | 안트로제네시스 코포레이션 | 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료 |
| WO2012091911A1 (en) * | 2010-12-27 | 2012-07-05 | Intellicell Biosciences, Inc. | Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
| KR101903339B1 (ko) * | 2011-03-22 | 2018-10-01 | 플루리스템 리미티드 | 방사선 또는 화학적 손상을 치료하는 방법 |
| DK2714059T3 (en) * | 2011-06-01 | 2019-01-21 | Celularity Inc | TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS |
| JP5598864B2 (ja) * | 2011-12-05 | 2014-10-01 | 北海道公立大学法人 札幌医科大学 | 細胞増殖方法ならびに組織の修復および再生のための医薬 |
-
2013
- 2013-06-26 JP JP2015518721A patent/JP2015521630A/ja active Pending
- 2013-06-26 CN CN201380044736.2A patent/CN104902909A/zh active Pending
- 2013-06-26 US US14/409,173 patent/US10206956B2/en active Active
- 2013-06-26 EP EP13808616.0A patent/EP2863927A4/en not_active Withdrawn
- 2013-06-26 KR KR1020157001923A patent/KR20150091037A/ko not_active Withdrawn
- 2013-06-26 WO PCT/AU2013/000684 patent/WO2014000029A1/en not_active Ceased
- 2013-06-26 AU AU2013284338A patent/AU2013284338B2/en active Active
- 2013-06-26 CA CA2877022A patent/CA2877022A1/en not_active Abandoned
- 2013-06-26 NZ NZ703345A patent/NZ703345A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sarvar et al. | Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy | |
| Malgieri et al. | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art | |
| Rota et al. | Stem cell therapies in kidney diseases: progress and challenges | |
| Katsuda et al. | The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles | |
| Suzuki et al. | Therapeutic effects of mesenchymal stem cell-derived exosomes in cardiovascular disease | |
| Nascimento et al. | Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms | |
| Grounds | Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances | |
| Gaebel et al. | Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration | |
| Thakker et al. | Mesenchymal stem cell therapy for cardiac repair | |
| Huang et al. | Stem cell therapies and regenerative medicine in China | |
| EA201790025A1 (ru) | Создание банка мезенхимальных стромальных клеток из объединенных мононуклеарных клеток нескольких доноров костного мозга | |
| Elnakish et al. | Mesenchymal stem cells for cardiac regeneration: translation to bedside reality | |
| JP2016539627A5 (enExample) | ||
| WO2012012737A3 (en) | Stable tregs and related materials and methods | |
| Bruno et al. | Dissecting paracrine effectors for mesenchymal stem cells | |
| JP2015061520A5 (enExample) | ||
| JP2014508799A5 (enExample) | ||
| Chowdhury et al. | Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence | |
| Tsao et al. | Mesenchymal stem cell derived exosomes: a new hope for the treatment of cardiovascular disease? | |
| Timari et al. | The effect of mesenchymal stem cell-derived extracellular vesicles on hematopoietic stem cells fate | |
| US20190117703A1 (en) | Immunological treatment of liver failure | |
| Kobielak et al. | Skin and skin appendage regeneration | |
| Mazo et al. | Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap | |
| CN111212654A (zh) | 用激活的调节性t细胞治疗肝衰竭 | |
| Lihua et al. | Effect of allogeneic umbilical cord mesenchymal stem cell transplantation in a rat model of hepatic cirrhosis |